Sutro Biopharma (NASDAQ:STRO) Price Target Cut to $16.00

Needham & Company LLC restated their buy rating on shares of CorMedix (NASDAQ:CRMD – Get Rating) in a report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a $13.00 price objective on the stock. Separately, JMP Securities reaffirmed a market outperform rating and set a $16.00 price target on shares of […]

Related Keywords

,Pinnacle Wealth Management Advisory Group ,Cormedix Inc ,Renaissance Technologies ,Pinnacle Associates Ltd ,Needham Company ,Get Rating ,Wealth Management Advisory Group ,Exoduspoint Capital Management ,Cormedix Daily ,Cormedix ,Nasdaq Crmd ,Crmd ,Medical ,Reiterated Rating ,Needham Company Llc ,